X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4082) 4082
Book Review (672) 672
Publication (347) 347
Newspaper Article (98) 98
Newsletter (75) 75
Book Chapter (25) 25
Conference Proceeding (15) 15
Book / eBook (14) 14
Magazine Article (6) 6
Dissertation (4) 4
Web Resource (4) 4
Data Set (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3541) 3541
polyamines (2078) 2078
humans (2071) 2071
animals (1907) 1907
male (993) 993
pharmacology & pharmacy (851) 851
female (764) 764
mice (708) 708
polyamines - chemistry (693) 693
polyamines - metabolism (590) 590
rats (581) 581
polyamines - therapeutic use (539) 539
biochemistry & molecular biology (530) 530
cancer (500) 500
sevelamer (405) 405
analysis (386) 386
middle aged (380) 380
metabolism (379) 379
proteins (370) 370
polyamines - pharmacology (364) 364
in-vitro (332) 332
cells (319) 319
oncology (316) 316
physiological aspects (315) 315
enzymes (311) 311
apoptosis (301) 301
cell line, tumor (298) 298
research (290) 290
gene expression (286) 286
ornithine decarboxylase (279) 279
adult (277) 277
spermine (273) 273
urology & nephrology (273) 273
aged (264) 264
polyamine (263) 263
medicine (252) 252
health aspects (245) 245
nanoparticles (235) 235
chemistry, multidisciplinary (233) 233
research article (230) 230
dose-response relationship, drug (229) 229
article (227) 227
spermidine (227) 227
chemistry, medicinal (223) 223
biochemistry, general (222) 222
cell biology (222) 222
life sciences (219) 219
dna (212) 212
drugs (207) 207
expression (207) 207
growth (206) 206
cell line (201) 201
chelating agents - therapeutic use (199) 199
cytotoxicity (198) 198
time factors (195) 195
amino acids (194) 194
inhibition (194) 194
polymers (194) 194
ornithine decarboxylase - metabolism (193) 193
cell survival - drug effects (187) 187
transfection (186) 186
drug delivery systems (184) 184
neurosciences (183) 183
biochemistry (182) 182
dendrimers (182) 182
gene delivery (176) 176
multidisciplinary sciences (174) 174
rodents (172) 172
therapy (172) 172
putrescine (171) 171
care and treatment (170) 170
in-vivo (170) 170
oxidative stress (169) 169
biosynthesis (167) 167
antineoplastic agents - pharmacology (159) 159
medicine, research & experimental (158) 158
metabolites (158) 158
science (158) 158
tumors (157) 157
molecular structure (154) 154
structure-activity relationship (154) 154
disease models, animal (153) 153
enzyme inhibitors (152) 152
gene transfer techniques (151) 151
rats, sprague-dawley (150) 150
cells, cultured (149) 149
biology (148) 148
chemotherapy (148) 148
genes (148) 148
polyamines - administration & dosage (147) 147
ornithine-decarboxylase (146) 146
calcium (145) 145
antineoplastic agents - therapeutic use (144) 144
rats, wistar (144) 144
renal dialysis (144) 144
materials science, biomaterials (142) 142
toxicity (142) 142
kinetics (141) 141
disease (140) 140
proteomics (138) 138
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4161) 4161
Japanese (47) 47
Russian (25) 25
French (18) 18
Spanish (14) 14
German (8) 8
Italian (4) 4
Polish (3) 3
Chinese (2) 2
Serbian (2) 2
Bulgarian (1) 1
Catalan (1) 1
Croatian (1) 1
Dutch (1) 1
Hungarian (1) 1
Portuguese (1) 1
Slovenian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 01/2016, Volume 11, Issue 1, pp. e0147389 - e0147389
Gene delivery holds therapeutic promise for the treatment of neurological diseases and spinal cord injury. Although several studies have investigated the use... 
LOCAL-DELIVERY | RECOVERY | STEM-CELLS | IN-VITRO | ACID | MULTIDISCIPLINARY SCIENCES | PLASMID DNA | CATIONIC LIPOSOME | BIODEGRADABLE NANOPARTICLES | FORMULATION | TRANSPLANTATION | Polylactic Acid-Polyglycolic Acid Copolymer | Nanospheres - chemistry | Polyglycolic Acid - pharmacology | Male | Spinal Cord Injuries - genetics | Vascular Endothelial Growth Factor A - metabolism | Motor Activity | Neural Stem Cells - cytology | Vascular Endothelial Growth Factor A - genetics | Recovery of Function | Spinal Cord Injuries - pathology | Cholesterol - chemistry | Biological Transport | Spinal Cord - pathology | Polyethyleneimine - chemistry | Lactic Acid - pharmacology | Spinal Cord Injuries - therapy | Transgenes | Injections, Spinal | Cholesterol - analogs & derivatives | Gene Transfer Techniques | Gene Expression | Lactic Acid - chemistry | Neural Stem Cells - drug effects | Rats | Polyethyleneimine - pharmacology | Spinal Cord - blood supply | Rats, Sprague-Dawley | Animals | Polyglycolic Acid - chemistry | Cholesterol - pharmacology | Mice | Primary Cell Culture | Neovascularization, Physiologic | Genetic Therapy - methods | Spinal cord | Transplants & implants | Biodegradability | Toxicity | Stem cell transplantation | Cytotoxicity | Lipids | Neurosurgery | Polyamines | Spinal cord injury | Polylactide-co-glycolide | Angiogenesis | Biomedical materials | Polyethylenimine | Transfection | Biocompatibility | Polyvinyl alcohol | Vascular endothelial growth factor | Injuries | Deoxyribonucleic acid--DNA | Biodegradation | Gene transfer | Tissue engineering | Medical treatment | Evaporation | Gene expression | Vectors (Biology) | Cholesterol | Neurological diseases | Medicine | Regeneration | Nanospheres | Stem cells | Neural stem cells | Spinal cord injuries | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Anti-Infective Agents, ISSN 2211-3525, 2014, Volume 12, Issue 1, pp. 95 - 103
Journal Article
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2018, Volume 2018, Issue 8, pp. CD006023 - CD006023
Background Phosphate binders are used to reduce positive phosphate balance and to lower serum phosphate levels for people with chronic kidney disease (CKD)... 
Bone Diseases | Metabolic [drug therapy | prevention & control]; Calcium [blood | JAPANESE HEMODIALYSIS-PATIENTS | Phosphorus [blood] | Calcium Compounds [adverse effects; therapeutic use] | RANDOMIZED CLINICAL-TRIAL | PERITONEAL-DIALYSIS PATIENTS | Parathyroid Hormone [blood] | Randomized Controlled Trials as Topic | Hypercalcemia [chemically induced] | MEDICINE, GENERAL & INTERNAL | PARATHYROID-HORMONE LEVELS | CORONARY-ARTERY CALCIFICATION | Polyamines [adverse effects; therapeutic use] | Sevelamer Humans | GROWTH-FACTOR 23 | ORAL FERRIC CITRATE | PLACEBO-CONTROLLED TRIAL | Kidney Diseases [blood; complications] | Chronic Disease | Chelating Agents [adverse effects; therapeutic use] | CHRONIC-RENAL-FAILURE | CALCIUM ACETATE/MAGNESIUM CARBONATE | Chronic Kidney Disease-Mineral and Bone Disorder - blood | Polyamines - adverse effects | Humans | Middle Aged | Polyamines - therapeutic use | Parathyroid Hormone - blood | Cause of Death | Sevelamer - therapeutic use | Calcium - blood | Calcium Compounds - adverse effects | Calcium Compounds - therapeutic use | Chronic Kidney Disease-Mineral and Bone Disorder - prevention & control | Adult | Iron Compounds - therapeutic use | Chelating Agents - therapeutic use | Iron Compounds - adverse effects | Lanthanum - adverse effects | Lanthanum - therapeutic use | Chelating Agents - adverse effects | Renal Dialysis - statistics & numerical data | Hypercalcemia - chemically induced | Chronic Kidney Disease-Mineral and Bone Disorder - drug therapy | Disease Progression | Phosphorus - blood | Aged | Index Medicus
Journal Article
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 05/2010, Volume 5, Issue 5, pp. 905 - 911
Background and objectives: Vitamin D deficiency is highly prevalent in chronic kidney disease. The aim of this study was to evaluate the effects of oral... 
BRAIN NATRIURETIC PEPTIDE | 1,25-DIHYDROXYVITAMIN-D3 | 1-ALPHA-HYDROXYLASE | RENAL-FAILURE | UROLOGY & NEPHROLOGY | 25-HYDROXYVITAMIN D3 | PREVALENCE | CHRONIC KIDNEY-DISEASE | VITAMIN-D DEFICIENCY | 1,25-DIHYDROXYCHOLECALCIFEROL | BLOOD-PRESSURE | Prospective Studies | Vitamin D Deficiency - complications | Erythropoietin - therapeutic use | Humans | Middle Aged | Vitamin D Deficiency - drug therapy | Ergocalciferols - therapeutic use | Male | Polyamines - therapeutic use | Parathyroid Hormone - blood | Bone Remodeling - drug effects | Calcium - blood | Erythropoietin - analogs & derivatives | C-Reactive Protein - metabolism | Cholecalciferol - administration & dosage | Time Factors | Vitamin D Deficiency - blood | Female | Kidney Diseases - blood | Kidney Diseases - complications | Sevelamer | Chelating Agents - therapeutic use | Natriuretic Peptide, Brain - blood | Hematinics - therapeutic use | Hypertrophy, Left Ventricular - blood | Administration, Oral | Hypertrophy, Left Ventricular - etiology | Hypertrophy, Left Ventricular - prevention & control | Inflammation Mediators - blood | Bone Density Conservation Agents - therapeutic use | Kidney Diseases - drug therapy | Treatment Outcome | Biomarkers - blood | Calcitriol - blood | Vitamin D - blood | Phosphorus - blood | Kidney Diseases - therapy | Vitamin D - analogs & derivatives | Aged | Darbepoetin alfa | Chronic Disease | Dietary Supplements | Vitamins - administration & dosage | Renal Dialysis | Serum Albumin - metabolism | Index Medicus | Original
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 06/2017, Volume 255, pp. 154 - 163
The development of new hetero-nanostructures for multifunctional applications in cancer therapy has attracted widespread attention. In this work, we put... 
Cellulose nanocrystal | Gold nanorod | Photoacoustic imaging | CD-PGEA | Combined therapy | DRUG | CELLS | DELIVERY-SYSTEMS | NANORODS | THERANOSTIC PLATFORM | CHEMISTRY, MULTIDISCIPLINARY | GLIOBLASTOMA | IN-VIVO | SILICA NANOPARTICLES | PHARMACOLOGY & PHARMACY | BIOMEDICAL APPLICATIONS | GENE TRANSFECTION | Polyamines - administration & dosage | Gold - administration & dosage | Cellulose - therapeutic use | DNA - therapeutic use | Polyamines - therapeutic use | Green Fluorescent Proteins - genetics | Methacrylates - chemistry | Cellulose - administration & dosage | Photoacoustic Techniques | Tumor Suppressor Protein p53 - genetics | Methacrylates - therapeutic use | Cellulose - chemistry | Hydroxyl Radical - therapeutic use | Neoplasms - therapy | Hydroxyl Radical - chemistry | Female | Nanostructures - therapeutic use | Gold - chemistry | Cell Survival - drug effects | Polyamines - chemistry | Methacrylates - administration & dosage | DNA - administration & dosage | Rats | Combined Modality Therapy | Neoplasms - drug therapy | Phototherapy | Hydroxyl Radical - administration & dosage | Animals | beta-Cyclodextrins - administration & dosage | beta-Cyclodextrins - chemistry | Mice, Nude | Nanostructures - administration & dosage | beta-Cyclodextrins - therapeutic use | Cell Line, Tumor | Gold - therapeutic use | Nanostructures - chemistry | Mice, Inbred BALB C | Antimitotic agents | Care and treatment | Hydroxides | Cellulose | Cyclodextrins | Antineoplastic agents | Health aspects | Cancer | Ethanolamines | Index Medicus
Journal Article